Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00091-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanepe&utm_campaign=update-lanepe&utm_medium=email&_hsmi=270216682&_hsenc=p2ANqtz--KhLWMavZWe090rnEoSybQjIhvRg09tSeQrcNp9JGvNoNpn9bigVbWLlW0ehb9-LcF-IqngPWSDPqoVLYS8s6SJSSi9A&utm_content=270181793&utm_source=hs_email